KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Change in Acquisitions & Divestments: 2010-2012

Historic Change in Acquisitions & Divestments for Emergent BioSolutions (EBS) over the last 3 years, with Dec 2012 value amounting to $2.0 million.

  • Emergent BioSolutions' Change in Acquisitions & Divestments was N/A to $2.0 million in Q1 2012 from the same period last year, while for Mar 2012 it was $6.2 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2012, which is 53.74% down from last year.
  • Per Emergent BioSolutions' latest filing, its Change in Acquisitions & Divestments stood at $2.0 million for FY2012, which was down 53.74% from $4.2 million recorded in FY2011.
  • In the past 5 years, Emergent BioSolutions' Change in Acquisitions & Divestments ranged from a high of $10.0 million in FY2010 and a low of $2.0 million during FY2012.
  • Its 3-year average for Change in Acquisitions & Divestments is $5.4 million, with a median of $4.2 million in 2011.
  • Data for Emergent BioSolutions' Change in Acquisitions & Divestments shows a maximum YoY crashed of 57.50% (in 2011) over the last 5 years.
  • Yearly analysis of 3 years shows Emergent BioSolutions' Change in Acquisitions & Divestments stood at $10.0 million in 2010, then crashed by 57.50% to $4.2 million in 2011, then crashed by 53.74% to $2.0 million in 2012.